Researchers from the University of Liverpool have shown the potential
Read moreRepurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19
Home »
Researchers develop model for SARS-CoV-2 fusion intermediate that helps membrane fusion
A model of the fusion intermediate shows that it is
Read moreSARS-CoV-2's resistance to remdesivir in vitro
With over 108 million reported infections from severe acute respiratory
Read moreResearchers develop ‘piggyback’ method to improve drug delivery of RNA therapeutics
A group of researchers from University of Toronto Engineering and
Read moreHorizon Therapeutics plc Announces U.S. FDA Approval of New Dosage Form for Procysbi (Cysteamine Bitartrate) Delayed-Release Oral Granules
DUBLIN–(BUSINESS WIRE)–February 18, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP)
Read morePear Therapeutics CEO explains app for addiction treatment
Smartphone apps have transformed the way we read the news,
Read moreAxsome Therapeutics Receives FDA Orphan Drug Designation for AXS-12 for the Treatment of Narcolepsy
NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) — Axsome Therapeutics,
Read moremiRagen Therapeutics Announces Initiation of Phase 2 Clinical Trial of MRG-201
BOULDER, Colo., July 10, 2018 (GLOBE NEWSWIRE) — miRagen Therapeutics,
Read moreAclaris Therapeutics Announces Positive Interim Data from Phase 2 study of ATI-502 (a topical JAK inhibitor) in Patients with Alopecia Areata
WAYNE, Pa., June 28, 2018 (GLOBE NEWSWIRE) — Aclaris Therapeutics,
Read more